IMHO, this explains why this stock has fallen to current price levels with relatively low volume. I was hoping this wasn't the case as it takes shameless balls to make this move with the cash on hand and big news coming within a month...
My gut is that neither Alkon nor Tuchman had much to do with this and that this is another Silverstein squared deal...
I would be willing to bet that they could have sold an option to a Big Pharma for better terms than this....
My disgust about this aside, this reinforces the stock's floor (which is pretty much the current price) and likely bodes well about their confidence in success. They are just grifting a piece off of those of us that have been carrying the risk over time...
Market Data 
Markets 
AI
